NPPA issued a notification regarding the computation of the Retail Price of Sulbactam Sodium (Sterile) IP equivalent to Sulbactam 500 mg + Meropenem (Sterile) IP equivalent to Anhydrous Meropenem 1000 mg + Sodium Carbonate (As buffer) (Sterile) IP equivalent to Sodium 90.2 mg for M/s Gufic Biosciences Ltd. (Manufacturer) & M/s Intas Pharmaceuticals Ltd. (Marketer)

Dec 01, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on November 26, 2025, issued a notification regarding computation of Retail Price of Sulbactam Sodium (Sterile) IP equivalent to Sulbactam 500 mg + Meropenem (Sterile) IP equivalent to Anhydrous Meropenem 1000 mg + Sodium Carbonate (As buffer) (Sterile) IP equivalent to Sodium 90.2 mg for M/s Gufic Biosciences Ltd. (Manufacturer) & M/s Intas Pharmaceuticals Ltd. (Marketer).

The following has been stated: -

•For each vial containing: Sulbactam Sodium (Sterile) IP equivalent to Sulbactam 500 mg + Meropenem (Sterile) IP equivalent to Anhydrous Meropenem 1000 mg + Sodium Carbonate (As buffer) (Sterile) IP equivalent to Sodium 90.2 mg for M/s Gufic Biosciences Ltd. (Manufacturer) & M/s Intas Pharmaceuticals Ltd. (Marketer), the retail price is 1824.88 Rs.

[Notification No.: 19(4908)/2025/DP/NPPA/Div.III/12561/2025]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT